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EDITORIAL
The kidney proteome: A hint of things to come
Proteomics can be defined as a systematic study of states to try to understand how the proteins present can
the proteins: their expression patterns, functions, and account for those differences.
interactions. It has also been defined as “any large-scale In this issue of Kidney International, Arthur et al [3]
or systematic characterization of the proteins present in a identify 54 unique proteins out of approximately 1000
cell, tissue, or organism [1]. Although the term is defined spots visualized on two-dimensional gels of proteins ex-
differently by different people, most would agree that it tracted from cortex and medulla. This analysis reflects
does not include the reductionist approach to the study a major limitation in the current approach to the study
of proteins one at a time that typified protein analysis of the proteome. [3] One hundred and eighty of the
prior to the genomic/proteomic era. The study of proteo- spots identified by two-dimensional electrophoresis were
mics represents a logical extension of “genomics,” which analyzed by excision, tryptic digestion, and peptide mass
deals with the characterization of a species DNA and fingerprinting using laser desorption ionization time-of-
gene expression patterns as reflected by mRNA levels. flight (MALDI-TOF) mass spectrometry. Compare this
Since it is the proteins, rather than the mRNA, that are “one spot at a time” approach to the genomic approach,
the true effectors of genes and since mRNA levels do which uses a chip containing 40,000 cDNAs to analyze
not always predict protein levels because of processing expression of that many genes simultaneously using sim-
events involving either the mRNA or protein or both, ple hybridization technology and fluorescence detection.
the study of proteomics holds the promise of providing In the study by Arthur et al, differential expression pat-
even more insight into functional significance afforded terns between cortex and medulla were explored [3]. Of
by gene expression than does the study of genomics. One the identified proteins, 16 were differentially expressed
problem with realizing this potential, however, is the with three expressed only in the medulla and one only
markedly greater complexity of the proteome. While in the cortex. Twelve proteins were expressed in both
there may be 35,000 to 50,000 genes [2], there are likely the cortex and medulla, but nine were expressed at
to be over 10 to 20 times that number of distinct proteins higher levels in the cortex and three at higher levels in
generated because of differential splicing and posttrans- the medulla. It is certainly not surprising that there are
lational modifications. In addition, there are serious tech- differences in protein expression between cortex and
nical issues that must be considered in the analysis of medulla. It is, in fact, surprising that Arthur et al did
the proteome. The study of genomics developed at a not find many more differences. We already know that
rapid pace once the study of gene expression moved there are many differences in protein expression along
from the “gel” phase, characterized by the study of one different regions of the nephron since specific transport-
or a few genes at a time followed by manual sequencing ers are localized to specific regions of the tubule. The
of those genes, to the rapid throughput technological complexity of the nephron is great and even if only trans-
revolution that enabled the study of tens of thousands port function is examined, many differences would be
of genes at once and the sequencing of millions of bases expected. For example, the distribution of Na,K
over extremely short periods of time. Proteomics repre- ATPase is very heterogenous along the nephron [4]. In
sents a much bigger challenge, given the complexity of addition, it is well known that metabolism is different
the proteome and the relatively limited analytic technol- along the various different segments [5]. Metabolic en-
ogy. In contrast to the Genome Project in which sequenc- zymes are expressed at different levels from segment to
ing of an entire genome was a finite, albeit daunting, segment of the nephron [6].
task, it is not possible to define a single proteome since The cortex is comprised predominantly of proximal
the proteins of an organism vary, depending upon age, tubules and would be expected to express proteins that
stage of development, influence of disease, and environ- are predominant in that segment of the nephron. There-
mental factors, including intra-organ and circulating fac- fore, it is not completely clear what new information
tors. The focus of proteomic research will not, in general, differential protein profiling comparing cortex and me-
be to catalog but rather to define differences between dulla will yield. As indicated by Arthur et al, it will be
most useful when a nephron segment-specific map of
protein expression is generated [3]. This will not beKey words: genomics, posttranslational modifications, laser desorption
ionization time-of-flight mass spectrometry, KIM-1. straightforward, given the requirement for microdissec-
tion and the small quantities of tissue that will, of neces- 2002 by the International Society of Nephrology
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sity, be available for analysis for such a map to be gener- (KIM-1), which is highly expressed with injury to the
proximal tubule in the human and rodent and is cleaved,ated. When this is achieved, however, it will provide the
student of the kidney with a segment or cell-type–specific releasing its ectodomain into the urine in a highly regu-
lated fashion [8].protein profile that can be related to function and begin
to provide a basis for “hypothesis building.” It will be In summary, we are embarking upon an exciting time,
the era of proteomics. We are progressing slowly becauseparticularly useful to be able to compare post-transla-
tional modifications, such as phosphorylation states, the tools necessary to facilitate progress are inadequate
to the daunting task before us. We can look forward toamong proteins across different segments. Many of the
regulatory aspects of protein function are not related to improved two-dimensional gel technology, higher through-
put mass spectroscopy, antibody and aptamer arrays, anddifferences in levels of the protein but to differences in
posttranslational modifications, such as phosphorylation. other future technologies, confident that the ingenuity
of the scientific community, aided by the imperatives ofDifferences in phosphorylation, for example, account for
the myriad functions of the mitogen-activated protein the biotechnology industry, will supply us with techno-
logical breakthroughs necessary to achieve higher(MAP) kinases [7]. Such knowledge will provide insight
into signal transduction pathways that couple to trans- throughput analyses. At that point, the onus will fall on
the biologist and clinician scientist to design the experi-port and metabolic function.
Proteomics will be an important tool for renal re- ments in such a way so as to optimize the interpretation
of the results, develop hypotheses derived from pro-search. Perhaps more tractable initially than a kidney
proteome will be a urinary proteome. An exhaustive teome data, and then test these hypotheses to facilitate
our understanding and treatment of diseases. This paperurinary proteome will be very valuable in defining those
proteins that are released into the urine under various by Arthur et al [3] is a hint of things to come.
types of disease states. This approach will be useful in
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